nifedipine has been researched along with alprostadil in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (31.58) | 18.7374 |
1990's | 15 (39.47) | 18.2507 |
2000's | 5 (13.16) | 29.6817 |
2010's | 6 (15.79) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Shimada, SG; Stitt, JT | 1 |
Kimblad, PO; Massa, G; Sjöberg, T; Solem, JO; Steen, S | 1 |
McLean, R; Pearl, RG; Prielipp, RC; Rosenthal, MH | 1 |
Finn, JC; Pearl, RG | 1 |
Francis, GS; Johnson, GJ; Leis, LA | 1 |
Müller, B; Schmidtke, M | 1 |
Müller, B; Schmidtke, M; Witt, W | 1 |
Nagao, I; Ogawa, K; Oida, A; Tsukada, K; Yoshimura, M | 1 |
Broughton Pipkin, F; Chinnery, E | 1 |
Bühler, FR; Erne, P; Resink, TJ | 1 |
Pearl, RG; Prielipp, RC; Rosenthal, MH | 1 |
Ikegami, K; Ueda, S; Yano, S; Yoshida, M | 1 |
Goldberg, HS; Halpern, SM; Jasper, AC; Koerner, SK; Lehrman, S; Shah, PK | 1 |
Fujihira, T; Fukuchi, Y; Imaizumi, T; Ishii, N; Kuroiwa, A; Miyahara, K; Nakashima, Y; Takasugi, M | 1 |
Fujii, I; Handa, S; Nakamura, Y; Ohonishi, S; Yamazaki, H | 1 |
Connolly, SM | 1 |
Ito, T; Kai, I; Ogawa, K | 1 |
Kawashima, A; Koike, H; Nishio, S; Ueno, Y | 1 |
Hibi, M; Iwase, J; Kawamura, M; Murakami, F; Usui, A; Yoshida, K | 1 |
Kimblad, PO; Steen, S | 1 |
Parizi, M; Rayan, GM; Tomasek, JJ | 1 |
Castillo Palma, MJ; Sánchez-Román, J; Talegón Meléndez, A; Varela-Aguilar, JM | 1 |
Kojima, M; Miyakawa, T; Ui, M | 1 |
Oonishi, T; Sakashita, K; Uyesaka, N | 1 |
LoCicero, J; McCully, JD; Sasaki, S; Yasuda, K | 2 |
Artemiou, O; Bîrsan, T; Klepetko, W; Kranz, A; Mares, P; Taghavi, S; Zuckermann, A | 1 |
Kurumatani, H; Matsushita, T; Tamura, M | 1 |
Akimaru, S; Ito, H; Katsube, N; Maegawa, H; Marsala, M; Nakai, K; Takenobu, Y; Takimizu, H | 1 |
Chan, KM; Hidaka, H; Hung, GH; Jones, RL; Lam, FF; Sasaki, Y; Suzuki, M | 1 |
De Lisle, RC | 1 |
Demir, B; Engin, MS; Keleş, MK; Küçüker, İ; Yosma, E | 1 |
1 review(s) available for nifedipine and alprostadil
Article | Year |
---|---|
Scleroderma: therapeutic options.
Topics: Alprostadil; Captopril; Colchicine; Griseofulvin; Humans; Immunosuppressive Agents; Nifedipine; Penicillamine; Phenytoin; Physical Therapy Modalities; Plasmapheresis; Prostaglandins E; Scleroderma, Systemic; Vasodilator Agents | 1984 |
1 trial(s) available for nifedipine and alprostadil
Article | Year |
---|---|
[Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex].
Topics: Adult; Aged; Alprostadil; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Misoprostol; Nifedipine; Raynaud Disease; Regional Blood Flow | 1997 |
36 other study(ies) available for nifedipine and alprostadil
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Calcium channel blockers inhibit endogenous pyrogen fever in rats and rabbits.
Topics: Alprostadil; Animals; Body Temperature; Brain; Calcium Channel Blockers; Fever; Interleukin-1; Male; Microinjections; Nifedipine; Pyrogens; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Stereotaxic Techniques; Verapamil | 1991 |
High potassium contents in organ preservation solutions cause strong pulmonary vasocontraction.
Topics: Alprostadil; Animals; Dose-Response Relationship, Drug; Hypertonic Solutions; Isotonic Solutions; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Organ Preservation; Potassium; Pulmonary Artery; Solutions; Swine | 1991 |
Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
Topics: Alprostadil; Animals; Blood Pressure; Cardiac Output; Epoprostenol; Heart Rate; Hemodynamics; Hypertension, Pulmonary; Isoproterenol; Nifedipine; Pulmonary Artery; Swine; Vascular Resistance; Vasodilator Agents | 1991 |
Hemodynamic effects of diltiazem during vasoconstrictor pulmonary hypertension in sheep.
Topics: Alprostadil; Animals; Diltiazem; Hemodynamics; Hypertension, Pulmonary; Male; Nifedipine; Sheep; Vasodilator Agents | 1990 |
Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
Topics: Adenosine; Alprostadil; Calcium Channel Blockers; Diltiazem; Drug Synergism; Epinephrine; Humans; In Vitro Techniques; Nifedipine; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Verapamil | 1990 |
Microvascular effects of iloprost in the hamster cheek pouch.
Topics: Alprostadil; Animals; Capillary Permeability; Cheek; Cricetinae; Epoprostenol; Iloprost; Male; Mesocricetus; Microcirculation; Nifedipine; Vasodilation | 1987 |
Action of the stable prostacyclin analogue iloprost on microvascular tone and -permeability in the hamster cheek pouch.
Topics: Alprostadil; Animals; Blood Pressure; Capillary Permeability; Cricetinae; Dose-Response Relationship, Drug; Epoprostenol; Iloprost; Male; Mesocricetus; Microcirculation; Mouth Mucosa; Muscle Tonus; Nifedipine; Permeability; Platelet Aggregation; SRS-A | 1987 |
[A case of primary pulmonary hypertension with beneficial effect of oral long-acting prostaglandin E1 and nifedipine].
Topics: Administration, Oral; Adult; Alprostadil; Delayed-Action Preparations; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension, Pulmonary; Nifedipine; Prognosis | 1989 |
The effect of a calcium antagonist, nitrendipine, on the responses of isolated strips of human, chorionic plate artery to prostaglandins E2 and E1.
Topics: Alprostadil; Arteries; Calcium Channel Blockers; Cesarean Section; Chorion; Dinoprostone; Female; Humans; In Vitro Techniques; Nifedipine; Nitrendipine; Pregnancy; Prostaglandins E; Random Allocation; Vasoconstriction | 1985 |
The influence of CGP 28392, a 1,4-dihydropyridine, on human platelet calcium and cyclic AMP metabolism.
Topics: Alprostadil; Blood Platelets; Calcium; Calcium Channel Blockers; Cyclic AMP; Humans; In Vitro Techniques; Kinetics; Nifedipine; Nitrendipine; Phosphorylation; Protein Kinases; Pyridines | 1985 |
Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in vasoconstrictor pulmonary hypertension in sheep.
Topics: Alprostadil; Animals; Drug Evaluation, Preclinical; Epoprostenol; Hemodynamics; Hypertension, Pulmonary; Isoproterenol; Lung; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Sheep; Vasodilation | 1988 |
Effects of prostaglandins on the isolated human minor calyx.
Topics: Alprostadil; Calcium; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Female; Humans; In Vitro Techniques; Kidney Calices; Kidney Pelvis; Male; Muscle Contraction; Nifedipine; Prostaglandins; Prostaglandins E; Prostaglandins F | 1986 |
Prostaglandin E1 as a screening vasodilator in primary pulmonary hypertension.
Topics: Adult; Aged; Alprostadil; Female; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Male; Middle Aged; Nifedipine; Oxygen; Pulmonary Circulation; Pulmonary Gas Exchange; Vasodilator Agents | 1987 |
Autopsy findings of the coronary arteries of variant angina with Raynaud's phenomenon of the tongue.
Topics: Adult; Alprostadil; Angina Pectoris, Variant; Cardiac Catheterization; Coronary Vessels; Drug Therapy, Combination; Electrocardiography; Humans; Isosorbide Dinitrate; Male; Nicardipine; Nifedipine; Raynaud Disease; Tongue Diseases; Valsalva Maneuver | 1986 |
Strategy to manage pump failure due to chronic pulmonary diseases--pathophysiology and treatment of right ventricular overload.
Topics: Alprostadil; Echocardiography; Heart; Heart Diseases; Heart Ventricles; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Nifedipine; Oxygen; Pulmonary Circulation; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1986 |
Effects of peripheral vasodilation caused by verapamil, nifedipine, and nitroglycerin on plasma prostaglandins and thromboxane concentrations.
Topics: 6-Ketoprostaglandin F1 alpha; Alprostadil; Animals; Dinoprost; Dogs; Female; Male; Nifedipine; Nitroglycerin; Prostaglandins; Prostaglandins E; Prostaglandins F; Pyridines; Thromboxane B2; Thromboxanes; Vascular Resistance; Vasodilation; Verapamil | 1982 |
Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice.
Topics: Administration, Oral; Alprostadil; Animals; Aspirin; Bridged Bicyclo Compounds; Collagen; Diltiazem; Drug Evaluation, Preclinical; Epinephrine; Epoprostenol; Fatty Acids, Monounsaturated; Fibrinolytic Agents; Heparin; Hydralazine; Injections, Intravenous; Isosorbide Dinitrate; Male; Mice; Nifedipine; Nitroprusside; Platelet Aggregation Inhibitors; Pulmonary Embolism; Superoxide Dismutase; Vasodilator Agents | 1995 |
The effects of calcium antagonists and prostaglandin E1 on isolated canine coronary arterial tension.
Topics: Alprostadil; Animals; Calcium; Calcium Channel Blockers; Coronary Vessels; Data Interpretation, Statistical; Diltiazem; Dogs; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Nicardipine; Nifedipine; Potassium; Sodium; Solutions; Verapamil | 1994 |
Eliminating the strong pulmonary vasoconstriction caused by Euro-Collins solution.
Topics: Alprostadil; Animals; Constriction, Pathologic; Drug Combinations; Drug Interactions; Endothelium, Vascular; Epoprostenol; Hypertonic Solutions; Models, Biological; Nifedipine; Papaverine; Phenylacetates; Pulmonary Artery; Severity of Illness Index; Sulfonamides; Swine; Thromboxane A2; Thromboxanes; Vasoconstriction; Vasodilator Agents | 1994 |
Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
Topics: Alprostadil; Angiotensin II; Calcium Channel Blockers; Dinoprost; Dinoprostone; Dupuytren Contracture; Fibroblasts; Humans; In Vitro Techniques; Lysophospholipids; Muscle Contraction; Nifedipine; Serotonin; Verapamil | 1996 |
Differential routes of Ca2+ influx in Swiss 3T3 fibroblasts in response to receptor stimulation.
Topics: 3T3 Cells; Alprostadil; Angiotensin II; Animals; Arachidonic Acid; Bombesin; Bradykinin; Calcium; Calcium Channel Blockers; Diltiazem; Endothelins; Enzyme Activation; GTP-Binding Proteins; Inositol Phosphates; Mice; Nifedipine; Pertussis Toxin; Phospholipases A; Phospholipases A2; Platelet-Derived Growth Factor; Protein Kinase C; Receptors, Cell Surface; Tetradecanoylphorbol Acetate; Thapsigargin; Thrombin; Vasopressins; Virulence Factors, Bordetella | 1998 |
Regulation of red blood cell filterability by Ca2+ influx and cAMP-mediated signaling pathways.
Topics: Adult; Alprostadil; Calcium; Calcium Channel Blockers; Cyclic AMP; Dinoprostone; Epinephrine; Erythrocyte Deformability; Erythrocytes; Felodipine; Filtration; Humans; In Vitro Techniques; Kinetics; Male; Nifedipine; Pentoxifylline; Signal Transduction; Stress, Mechanical | 1997 |
Calcium channel blocker enhances lung preservation.
Topics: Adenosine; Airway Resistance; Allopurinol; Alprostadil; Animals; Calcium Channel Blockers; Glutathione; Insulin; Lung Compliance; Lung Transplantation; Male; Nifedipine; Organ Preservation Solutions; Oxygen; Potassium; Pulmonary Gas Exchange; Raffinose; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 1999 |
Does PGE1 attenuate potassium-induced vasoconstriction in initial pulmonary artery flush on lung preservation?
Topics: Alprostadil; Animals; Calcium Channel Blockers; Injections, Intra-Arterial; Lung; Lung Transplantation; Male; Nifedipine; Organ Preservation; Organ Preservation Solutions; Potassium; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Ryanodine; Vasoconstriction; Vasodilator Agents | 1999 |
Transient left ventricular failure following bilateral lung transplantation for pulmonary hypertension.
Topics: Adult; Alprostadil; Antihypertensive Agents; Cardiac Output, Low; Cardiotonic Agents; Catheterization, Swan-Ganz; Clonidine; Dobutamine; Echocardiography; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Transplantation; Male; Nifedipine; Respiratory Insufficiency; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 1999 |
Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Antihypertensive Agents; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Epoprostenol; Humans; Hypertension, Pulmonary; Male; Nifedipine; Nitroglycerin; Oxygen; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
Effects of OP-1206 alpha-CD on walking dysfunction in the rat neuropathic intermittent claudication model: comparison with nifedipine, ticlopidine and cilostazol.
Topics: Alprostadil; Animals; Body Weight; Cilostazol; Disease Models, Animal; Exercise Test; Intermittent Claudication; Male; Nifedipine; Platelet Aggregation; Rats; Rats, Wistar; Skin; Spinal Cord; Tetrazoles; Ticlopidine; Time Factors; Walking | 2003 |
Investigation of the pronounced synergism between prostaglandin E2 and other constrictor agents on rat femoral artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Dinoprostone; Drug Interactions; Drug Synergism; Femoral Artery; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Male; Nifedipine; Phenylephrine; Potassium; Prostaglandins F, Synthetic; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP3 Subtype; rho-Associated Kinases; Sensitivity and Specificity; Sulfonamides; Vasoconstrictor Agents | 2006 |
Lubiprostone stimulates small intestinal mucin release.
Topics: Alprostadil; Animals; Indomethacin; Intestine, Small; Lubiprostone; Male; Mice; Mice, Inbred C57BL; Mucins; Muscle, Smooth; Nifedipine | 2012 |
Comparison of the effects of different vasoactive and antiplatelet drugs on perforator flap viability. An experimental study.
Topics: Alprostadil; Animals; Arteries; Epigastric Arteries; Graft Survival; Hydralazine; Nifedipine; Perforator Flap; Piracetam; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2016 |